上海优拓医药科技有限公司_公司详情_供应商_CPHI制药在线专业网上贸易平台

制药在线首页

公司概况
成立年份： 2004
总资产(USD)： 2,000,000至2,999,999
员工总人数： 20至29
主要竞争优势：品牌，经验丰富的研发人员，生产能力，产品线丰富，合同定制，接受买家的规格要求，接受小额订单，良好的信誉，优质服务
其他竞争优势：
技术攻关能力强，擅长工艺优化。
专利与版权： Our patents situation: Ivabradine HCl: CN101284813B, CN101353325B Ulipristal Acetate: CN102675395B，CN103755765A， ULIPRISTAL ACETATE PREPARATION METHOD AND INTERMEDIATE THEREOF EP2774933 (A1) EP2774933 (A4) US2014296510 (A1) US9163058 (B2) RU2014120908 (A) MX2014005245 (A) JP2014528459 (A) JP5913599 (B2) CN102516345 (A) CN102516345 (B) WO2013063859 (A1) CA2851399 (A1) AU2012331996 (A1) AU2012331996 (B2) IN2562/CHENP/2014 Apremilast: CN201410335852.6, APREMILAST PREPARATION METHOD AND INTERMEDIATE THEREOF WO2016141503, CN104761484 (A) , A STABLE APREMILAST CRYSTAL FORM II FREE OF SOLVATES AND A PREPARING METHOD THEREOF

业务概况
业务类型：制造商，出口商，零售商
年销售额(USD)： 4,000,000至4,999,999
主要销售市场：北美洲，中/南美洲，西欧，东欧，大洋洲，亚洲，中东
主要产品类别：原料药，中间体，药品制剂，合同外包、定制服务及咨询
所有产品：
● 阿戈美拉汀 ● 甲磺酸雷沙吉兰 ● 依普利酮 ● 盐酸伊伐布雷定 ● 阿立哌唑 ● 比卡鲁胺 ● 烯丙雌醇 ● 琥珀酸亚铁 ● 利克飞龙 ● 托伐普坦 ● 普拉格雷 ● 顺苯磺酸阿曲库铵 ● 醋酸乌利司他，阿奇沙坦，阿普司特及其中间体。
外销比重： 50
内销比重：
主要客户：

其它信息
合同定制：
付款条款：

公司详情

UTOpharm（Shanghai）Co., Ltd., founded in 2004 in Shanghai, specialized in development，manufacture and marketing of pharmaceutical intermediates and APIs.

UTOpharm has its own research center and production base. The research center is located in Shanghai, owning a strong innovative research and development team with rich experience in organic synthesis area and specializing in research & development of new products and optimization of new production process. The production base is located in Ningbo, Zhejiang province. UTOpharm is equipped with a variety of equipments(1-3000L), including two low–temperature reaction kettles (500L, -70℃) and one hydrogen reactor (500L, 11mPa), which can satisfy a variety of chemical reaction from small-scale tests, pilot experiments and scale up production. Meanwhile, our company is equipped with many analytical devices, such as HPLCs and GC.

UTOpharm lays great emphasis on the customer's demands and regards customer satisfaction as its priority all the time. Furthermore, UTOpharm is endeavored in establishing long-term, various, and mutual-benefit cooperation with companies worldwide.

Basic Activities on:

Pre-clinical research of generic drugs;

Contract research;

Contract synthesis;

Contract manufacturing;

Registration of drugs;

Optimization of synthesis process;

Our patents situation:

Ivabradine HCl:

CN101284813B, CN101353325B

Ulipristal Acetate: CN102675395B，CN103755765A，

ULIPRISTAL ACETATE PREPARATION METHOD AND INTERMEDIATE THEREOF
EP2774933 (A1) EP2774933 (A4) US2014296510 (A1) US9163058 (B2) RU2014120908 (A) MX2014005245 (A) JP2014528459 (A) JP5913599 (B2) CN102516345 (A) CN102516345 (B) WO2013063859 (A1) CA2851399 (A1) AU2012331996 (A1) AU2012331996 (B2) IN2562/CHENP/2014

Apremilast:

CN201410335852.6, APREMILAST PREPARATION METHOD AND INTERMEDIATE THEREOF

WO2016141503, CN104761484 (A) , A STABLE APREMILAST CRYSTAL FORM II FREE OF SOLVATES AND A PREPARING METHOD THEREOF

里程碑

2004年:成立

2012年：投资500万，建立生产车间

行业新闻